Molecular Inc.

Howard M. Kogan is the President of Molecular. In this role, he oversees all client facing, business development and marketing activities at Molecular. He also guides the Molecular leadership team in developing the overall strategy and direction of the company. Kogan previously served in several executive roles at Molecular, including Chief Operating Officer, Vice President of Client Services, and Director of Engineering. Prior to Molecular, Kogan held various senior management positions in the Internet and telecommunications industries, leading and collaborating on projects related to strategic process improvement, research and development, and new business development. Kogan received a BS in Mathematics/Computer Science from Binghamton University and an MS in Software Engineering from Boston University.

Array

Frank Walsh received his Ph.D. in Biochemistry from University College, London, in 1977. He then undertook a one-year post doctoral research fellowship at the National Institute of Health (NIH) in Bethesda, Maryland, USA, returning to the UK in 1979 to the Institute of Neurology in London. In 1989, Frank moved to the United Medical and Dental Schools of Guy?s and St. Thomas?s Hospitals (UMDS), London, becoming the Sir William Dunn Professor of Experimental Pathology, and later served as the UMDS?s Research Dean. In 1997, Frank moved to SmithKline Beecham (SB) Pharmaceuticals at Harlow, UK, to become Vice President and Director of Neuroscience Research. With the creation of GSK from the merger of SB and GW, Frank became Senior Vice President and Head of the Company?s Neurology-CEDD. In 2002, Frank moved to Wyeth Research, Collegeville, Pennsylvania, USA, to become Senior Vice President and Head of Discovery Research. Frank serves on a number of advisory boards, including those of the UK Medical Research Council?s Centre for Developmental Neurobiology and the ALS Research Center at Johns Hopkins University, Baltimore, USA. He is also the Chairman of the UK Muscular Dystrophy Campaign?s Research Committee, and he holds Visiting Professorships at London University?s King?s College, and University College Dublin. Frank is currently Chief Editor of the journal, Molecular and Cellular Neuroscience.

Amy E. Quigley, Vice President of Marketing at Molecular, is responsible for providing strategic and visionary leadership to the marketing team by driving innovation and delivering targeted and integrated marketing solutions. On a daily basis, she oversees public relations, demand generation, analyst relations and Molecular's thought leadership initiatives. Amy also assures that all marketing strategies are consistent with overall company objectives. Throughout her career, Amy has developed experience in a variety of industries ranging from high tech and financial services, to fashion and not-for-profit organizations. Prior to Molecular, she was responsible for developing and executing marketing strategies at ATG, Fidelity Investments and Bank of Boston, and she contributed to the marketing strategy for two fashion start-ups. Amy also spent several years at Leo Burnett/Boston where she managed several major accounts, including CMGI, Keane and exchange.com (acquired by Amazon.com), developing strategies to articulate their business objectives and values into succinct and influential brand messages. Amy graduated from the University of Hartford with a BA in Communications.

Don S. Bell is the Vice President of Project Management at Molecular. In this role, he manages the day-to-day operation of the project management team and sets the strategic direction for how Molecular delivers rigorous achievement of business results to clients. In addition, Bell ensures that the latest project methodologies are integrated into client's project portfolios. Before joining Molecular, Bell worked at iXL, a technology consulting company focused on Web strategy, design and development. In his role as Director of Technology, he was responsible for defining strategic technical direction for iXL's clients. Bell received a BS in Industrial Engineering from Lehigh University.

Rob Parrish, Vice President of Human Resources, is responsible for aligning Molecular's business strategy and goals with the goals and needs of our employees by creating practices, processes and tools that support our shared interests. A dynamic culture with inspired and best in class talent enables Molecular to deliver best in class solutions for our clients. With over 20 years of human resources management experience, Parrish has held positions in some of the country's leading media, advertising, technology, and retail firms. Parrish joined Molecular in 2000, after serving as Global Director of Human Resources for Zentropy Partners, an e-business unit of the Interpublic Group of Companies. In this capacity, he was responsible for creating and leading global human resources services function. Parrish also served as Vice President of Human Resources for Hill, Holliday, and integrated marketing communications firm headquartered in Boston. Parrish received a B.A. in Art History from the University of Vermont and an MBA in Human Resources Management from the Kelley School of Business at Indiana University.

Scott J. Cleversey, Vice President, is responsible for overseeing strategic business development activities that engage new customers and expand Molecular's service into new markets. His team focuses on working with Fortune 500 clients, directly and through strategic relationships. Through his extensive e-business experience and strategic savvy, Cleversey has led countless clients to achieving their goals to improve their online channel results. He is also responsible for efforts focused on strategic partnerships and services. Prior to his current role, Cleversey held a series of leadership positions in sales management and played a key role in solutions development activities. Since joining Molecular in 1997, Cleversey has worked directly with clients such as Hewlett-Packard, UPS, PerkinElmer, Philips, Yankee Candle, Burton and Rentokil Initial. Prior to his tenure with Molecular, Cleversey worked at Panasonic, a leading international consumer goods firm. There he managed key client relationships, customer satisfaction, quality assurance, and research and development for his team. In addition, Scott has also worked in engineering, design, and reliability as an application engineer at United Technologies, Carrier Corporation. Cleversey holds a BS in Mechanical Engineering from Syracuse University.

Bart De Strooper, MD, PhD, is professor in molecular medicine and chairman of the department for human genetics at K.U.Leuven. He is also the scientific director of the VIB department of Molecular and Developmental Genetics where he operates the laboratory of neuronal cell biology and gene transfer. His group consists of about 30 researchers coming from over 15 different countries all over the world. Bart and his team investigate the fundamental mechanisms that cause Alzheimer's disease and Parkinson disease. Their work on the presenilin/gamma-secretase has led them into the area of regulated intramembrane proteolysis, a novel cell signaling pathway. Bart received his M.D. in 1985 and Ph.D. in 1991 from K.U.Leuven , Belgium . He did a postdoc in the European Molecular Biology Laboratory (EMBL) in Heidelberg , Germany , in the laborartory of Carlos Dotti. Bart has won numerous prizes for his work on Alzheimer's disease. In 2002 he received the Potamkin Prize for Research in Pick's, Alzheimer's and related Diseases and the Pioneer Award of the Alzheimer's Association (USA). In 2003 he received the Alois Alzheimer Award of the Deutscher Gesellschaft fur Gerontopsychiatrie und Psychotherapie. In 2005 he received the Vijfjaarlijkse Joseph Maisin Prize for biomedical research of the Flamish research organizaiton and in 2008 he received the MetLife Foundation Award for Medical Research (USA).

Bryant Shea, Director of Content Management at Molecular, has over 12 years experience leading complex technology and marketing efforts in both the public and private sector. At the helm of Molecular's Content Management practice, Bryant has established this group as a nationally-recognized leader in the content management (CM) space through external thought leadership and world class delivery. His group is an innovator in CM technologies and implementations with experience in leading and managing worldwide enterprise content management (ECM) projects for Fortune 500 companies.

Cameron is responsible for the stewardship of innovation, quality and best practice development on the engineering team. Working with the other regional engineering leads, Cameron collects, condenses, and conveys lessons learned across the group, and ensures that these are used to evolve Molecular's engineering capabilities to best serve clients' business needs. Cameron also serves as the Director of Engineering for the Boston Office. As such, he is responsible for leading a team of over 30 technical architects and developers in designing, implementing and evangelizing Internet-based solutions that solve business problems. In addition to working on client projects, Cameron has led Molecular's Innovation Factory, an ongoing initiative that researches, evaluates and applies emerging technologies in new and different ways to move businesses forward. Cameron has over eleven years of consulting and management experience that spans the retail, high-tech, energy services, and telecommunications industries. Prior to Molecular, he spent three years with Accenture and six years as CTO of Envisa, a consulting firm which he co-founded. Cameron holds an A.B. in Chemistry from Princeton University and a Ph.D. in Chemistry (concentrating in computer simulations) from Harvard University. He was also a visiting scholar at the Swiss Federal Institute of Technology (ETH) in Zurich.

Riccardo La Rosa is Director of Emerging Interactions at Molecular, and has over a decade of experience in architecting, designing and building innovative solutions on the web. His roots are in software engineering and when he is not involved in one of his social networks or digital worlds, he does real work for clients like Reebok, Adidas, Bank Of America, Fidelity, Staples, McGraw-Hill, and Adobe. Prior to leading the Emerging Interactions practice, Riccardo was a Principal Consultant, technical architect at Molecular where he focused his technology expertise on business analysis, requirements gathering, and solutions architecture. Over the years, Riccardo has developed a deep knowledge in the financial, retail and manufacturing industries. Riccardo leads presentations and seminars on all aspects of Web 2.0 including User-Generated Content and Rich Internet Experiences at events including AJAXWorld Conference and Expo, Babson College Executive Education, eFusion 2006, and the Enterprise Architect Summit. Before joining Molecular, Riccardo worked as a consultant for companies including, Massachusetts General Hospital and Malden Mills. He holds a Master of Science Degree in Electronic Engineering from Universita di Padova, Italy. During that time he wrote his thesis on "High Power Factor Electronic Ballasts" at Brown University.

Steve Mulder is Director of Emerging Interactions at Molecular, author of The User Is Always Right: A Practical Guide to Creating and Using Personas for the Web, and a regular speaker at web conferences. With over ten years of experience in user research, information architecture, interaction design, and usability, Steve practices what he preaches by delivering successful user experiences that drive business results. He has brought his expertise to a wide range of companies, including Morgan Stanley, PC Connection, 3M, CVS, Estee Lauder, Talbots, Wired, Terra Lycos, and ZDNet.

Dr. Belmont is active as both a clinician and a research scientist at Baylor College of Medicine. He serves as an Associate Professor, with appointments in the departments of Molecular and Human Genetics, Pediatrics, Microbiology and Immunology. He is also founder and Co-Director of the Cardiovascular Genetics Clinic at Texas Children's Hospital. Dr. Belmont obtained a B.A. in Microbiology from the University of Texas at Austin in 1974. He earned his Ph.D. and M.D. degrees from Baylor College of Medicine in 1980 and 1981 respectively. He maintains certification by the American Board of Pediatrics and the American Board of Medical Genetics. Dr. Belmont has published extensively on topics in immunology, human genetic disorders, and stem cell biology.

Dr. Chan is the Betty Rutherford Chair for Diabetes Research and is the director of the Center for Molecular Medicine at Baylor College of Medicine in Houston, Texas. He is also professor in the departments of Medicine and Molecular and Cellular Biology. He is recognized as an authority in the genetics of atherosclerosis and lipid disorders. Dr. Chan was the recipient of a MERIT Award from the National Institutes of Health and is principal investigator of four NIH grants including a NIH Specialized Center of Research Grant on gene therapy and cardiovascular disease. He has received numerous national and international honors and awards from organizations including the American Heart Association and the Juvenile Diabetes Association. He is also an elected member of the American Society for Clinical Investigation and the Association of American Physicians.

Nicole King specializes in bio-science leadership and management for Dynamic Learning Systems. She is an Assistant Professor in the departments of Molecular and Cell Biology (Division of Genetics, Genomics, and Development) and of Integrative Biology at the University of California at Berkeley, and she is a member of the Center for Integrative Genomics. Nicole leads a research team that studies the origin and evolution of the animal genome, and focuses on the transition to multicellularity. Having worked in five very different research settings prior to starting her own lab at the UC-Berkeley, Nicole has experienced a wide array of research management styles and situations, ranging from highly effective, high performing teams to utterly disastrous ones. Nicole is therefore dedicated to identifying and implementing successful leadership and management strategies in her own work and in our clients organizations. As a consultant with Dynamic Learning Systems, Nicole s expertise and experience as a successful scientist, team leader, and manager gives her a unique and focused insight. With an intimate understanding of the context, she applies Dynamic Learning Systems technology for creating safe-to-day, innovative environments in a way that leads to the greatest possible leverage for our biotech clients. Nicole holds a Ph.D. in biochemistry from Harvard University. She is a MacArthur Foundation Fellow (2005), a Pew Scholar in the Biomedical Sciences (2004), and recipient of the George Bartholomew Award in Integrative Physiology (2004). She has published in Science, Nature, Developmental Cell, and PNAS. Her passions include the outdoors (hiking and sculling) and her family, especially her newborn son, Nathaniel.

Christine is responsible for counselling clients on mobile and helping them bridge their digital strategies to include this rapidly-emerging marketing and communications platform. A veteran of the mobile marketing industry, Christine has pioneered mobile marketing strategies for leading brands, entertainment companies, and wireless carriers for over six years. Prior to Molecular, Christine was an early employee at m-Qube, a mobile marketing and enablement firm (later sold to VeriSign), where she advised clients on marketing strategies and created unique mobile programs for clients. Christine's mobile marketing expertise was instrumental in launching a number of industry 'firsts,' including the first ever cross-carrier mobile marketing program for P architecting and managing the largest ever interactive television program for Endemol, Deal or No Deal; and the first national mobile video alert service for CBS. In 2006, her original mobile marketing program for Pontiac, 'Catch a G6' was awarded Interactive Marketing Award of 2006 by Promo Magazine for best promotional work in digital technologies. Christine has spoken at industry events including the Informa Off-Deck Conference and iMedia Financial Marketing Summit. She has a bachelor's degree in Economics from Boston College's Carroll School of Management, where she is currently studying for her MBA.

Eric Jakobsson, Ph.D., is a faculty member in the department of Molecular and Integrative Physiology at the University of Illinois at Urbana-Champaign. He also holds appointments at the National Center for Supercomputing Applications and the Beckman Institute. His research uses computational simulation and bioinformatics in the areas of computer-aided design of components for nanodevices, structure of biological membranes, structure-function relationships in biological and synthetic ion channels, computer-aided drug research, comparative genomics of microbes, use of technology to introduce advances in biology and chemistry education.

Dr. Krumlauf is the Scientific Director at the Stowers Institute for Medical Research. He also holds joint appointments as Professor in the University of Kansas Neuroscience Graduate Program, in the University of Kansas Medical School Department of Anatomy and Cell Biology and Department of Biochemistry and Molecular Biology, and in the UMKC School of Dentistry Department of Oral Biology. Prior to his arrival in Kansas City, Dr. Krumlauf was the Division Head of Developmental Neurobiology at the National Institute for Medical Research in London. Dr. Krumlauf received his B.E. in chemical engineering from Vanderbilt University. He worked as the Chief Chemical Engineer in charge of Biomedical Research and Pilot Operations at the Capital City Products Division of Stokley Van Camp before returning to graduate school to earn his Ph.D. in developmental biology from the Ohio State University. Dr. Krumlauf did postdoctoral training as a NATO/NSF and SHERT fellow at the Beatson Institute for Cancer Research in Glasgow, Scotland; followed by additional training as an NIH Postdoctoral Fellow at the Institute for Cancer Research in Philadelphia, PA under the direction of Dr Shirley Tilghman current President of Princeton University. He was elected as a member in both the European Molecular Biology Organisation and the Academy of Medical Sciences of the United Kingdom. Dr. Krumlauf sits on the Board of Directors of the Stowers Institute for Medical Research, the International Advisory Board of the Wellcome Trust-Cancer Research UK Institute, and chairs the Scientific Advisory Board of Endogeny Bio Corporation in Rockville MD. He is a member of numerous scientific societies, serves as the Editor of Developmental Biology, and sits on the editorial boards of the EMBO Journal, Development, Molecular and Cellular Neurobiology, and Nucleic Acids Research. Dr. Krumlauf performs research in the fields of neurobiology, embryology and developmental biology and has published more than 160 articles in peer-reviewed journals.